UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.e870-e876

2011

Volltextzugriff (PDF)

A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management

Journal of thrombosis and haemostasis, 2012-03, Vol.10 (3), p.359-367

2012

Volltextzugriff (PDF)

The role of point-of-Care Musculoskeletal Ultrasound for Routine Joint evaluation and management in the Hemophilia Clinic - A Real World Experience

BMC musculoskeletal disorders, 2022-12, Vol.23 (1), p.1111-1111, Article 1111

2022

Volltextzugriff (PDF)

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1788-1800

2014

Volltextzugriff (PDF)

PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleeding

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.832-843

2017

Volltextzugriff (PDF)

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.104-112

2018

Volltextzugriff (PDF)

Pocket handheld ultrasound for evaluation of the bleeding haemophilic joint: A novel and reliable way to recognize joint effusions

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.e77-e80

2018

Volltextzugriff (PDF)

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A‐LONG study subjects with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.392-399

2017

Volltextzugriff (PDF)

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A‐LONG and Kids A‐LONG Studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-01, Vol.23 (1), p.e39-e42

2017

Volltextzugriff (PDF)

Safety and efficacy of plasma-derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-01, Vol.17 (1), p.e196-e201

2011

Volltextzugriff (PDF)

How we treat: Haematuria in adults with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (4), p.683-685

2010

Volltextzugriff (PDF)

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-11, Vol.18 (6), p.881-887

2012

Volltextzugriff (PDF)

Reduced Transcription of the Ferredoxin Gene in Metronidazole-Resistant Trichomonas vaginalis

Proceedings of the National Academy of Sciences - PNAS, 1992-05, Vol.89 (10), p.4402-4406

1992

Volltextzugriff (PDF)

Same day outpatient transjugular liver biopsies in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-11, Vol.10 (6), p.727-731

2004

Volltextzugriff (PDF)

Proteolytic Processing of the β-Subunit of the Lysosomal Enzyme, β-Hexosaminidase, in Normal Human Fibroblasts

The Journal of biological chemistry, 1989-02, Vol.264 (6), p.3380-3384

1989

Volltextzugriff (PDF)

Similarity Between a Ubiquitous Promoter Element in an Ancient Eukaryote and Mammalian Initiator Elements

Proceedings of the National Academy of Sciences - PNAS, 1994-05, Vol.91 (10), p.4579-4583

1994

Volltextzugriff (PDF)

Proteolytic processing of the alpha-chain of the lysosomal enzyme, beta-hexosaminidase, in normal human fibroblasts

The Journal of biological chemistry, 1988-03, Vol.263 (9), p.4288-4292

1988

Volltextzugriff (PDF)

A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE)

Journal of blood medicine, 2021-01, Vol.12, p.883-896

2021

Volltextzugriff (PDF)

Two mutations produce intron insertion in mRNA and elongated beta-subunit of human beta-hexosaminidase

The Journal of biological chemistry, 1990-10, Vol.265 (29), p.17921-17927

1990

Volltextzugriff (PDF)

Advanced phase I/II evaluation of tumor-targeted gene delivery: Intravenous retrovector encoding mutant anticyclin G1 as stand-alone therapy for chemotherapy-resistant bone and soft tissue sarcoma

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10010-10010

2010

Volltextzugriff (PDF)

Phase I and II studies of intravenous Rexin-G as monotherapy for stage IVb gemcitabine-resistant pancreatic cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4149-4149

2010

Volltextzugriff (PDF)

Pharmacokinetic properties of IB 1001, an investigational recombinant factor IX , in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-11, Vol.18 (6), p.881-887

2012

Volltextzugriff (PDF)

Transcription in the early diverging eukaryote Trichomonas vaginalis: an unusual RNA polymerase II and alpha-amanitin-resistant transcription of protein-coding genes

Journal of molecular evolution, 1996-09, Vol.43 (3), p.253-262

1996

Volltextzugriff (PDF)

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

The New England journal of medicine, 2022-03, Vol.386 (11), p.1013-1025

2022

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(89)
Tagungsberichte
(1)

Sprache

Englisch
(90)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis

A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management

The role of point-of-Care Musculoskeletal Ultrasound for Routine Joint evaluation and management in the Hemophilia Clinic - A Real World Experience

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleeding

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Pocket handheld ultrasound for evaluation of the bleeding haemophilic joint: A novel and reliable way to recognize joint effusions

Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A‐LONG study subjects with severe haemophilia A

Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A‐LONG and Kids A‐LONG Studies

Safety and efficacy of plasma-derived coagulation factor IX concentrate (AlphaNine® SD) in patients with haemophilia B undergoing surgical intervention: a single institution retrospective analysis

How we treat: Haematuria in adults with haemophilia

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Reduced Transcription of the Ferredoxin Gene in Metronidazole-Resistant Trichomonas vaginalis

Same day outpatient transjugular liver biopsies in haemophilia

Proteolytic Processing of the β-Subunit of the Lysosomal Enzyme, β-Hexosaminidase, in Normal Human Fibroblasts

Similarity Between a Ubiquitous Promoter Element in an Ancient Eukaryote and Mammalian Initiator Elements

Proteolytic processing of the alpha-chain of the lysosomal enzyme, beta-hexosaminidase, in normal human fibroblasts

A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE)

Two mutations produce intron insertion in mRNA and elongated beta-subunit of human beta-hexosaminidase

Advanced phase I/II evaluation of tumor-targeted gene delivery: Intravenous retrovector encoding mutant anticyclin G1 as stand-alone therapy for chemotherapy-resistant bone and soft tissue sarcoma

Phase I and II studies of intravenous Rexin-G as monotherapy for stage IVb gemcitabine-resistant pancreatic cancer

Pharmacokinetic properties of IB 1001, an investigational recombinant factor IX , in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

Transcription in the early diverging eukaryote Trichomonas vaginalis: an unusual RNA polymerase II and alpha-amanitin-resistant transcription of protein-coding genes

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A

Suchergebnisse filtern